CD7+ Lymphoma
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation (NCT07117305) | Zhengzhou University | 2025-09-01 |
| CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia (NCT07008872) | Qi deng | 2025-06-01 |
| Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy (NCT04599556) | Zhejiang University | 2021-04-01 |
Track CD7+ Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.